GB1596592A - Hb ab human plasma - Google Patents

Hb ab human plasma Download PDF

Info

Publication number
GB1596592A
GB1596592A GB23093/79A GB2309379A GB1596592A GB 1596592 A GB1596592 A GB 1596592A GB 23093/79 A GB23093/79 A GB 23093/79A GB 2309379 A GB2309379 A GB 2309379A GB 1596592 A GB1596592 A GB 1596592A
Authority
GB
United Kingdom
Prior art keywords
hbc
human plasma
rotor
human
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23093/79A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1596592A publication Critical patent/GB1596592A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5762—Hepatitis B core antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB23093/79A 1977-04-20 1978-04-18 Hb ab human plasma Expired GB1596592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,033 US4102996A (en) 1977-04-20 1977-04-20 Method of preparing hepatitis B core antigen

Publications (1)

Publication Number Publication Date
GB1596592A true GB1596592A (en) 1981-08-26

Family

ID=25146371

Family Applications (3)

Application Number Title Priority Date Filing Date
GB23093/79A Expired GB1596592A (en) 1977-04-20 1978-04-18 Hb ab human plasma
GB44611/79A Expired GB1596593A (en) 1977-04-20 1978-04-18 Hepatitis b core antigen
GB15228/78A Expired GB1596591A (en) 1977-04-20 1978-04-18 Hepatitis b core antigen

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB44611/79A Expired GB1596593A (en) 1977-04-20 1978-04-18 Hepatitis b core antigen
GB15228/78A Expired GB1596591A (en) 1977-04-20 1978-04-18 Hepatitis b core antigen

Country Status (14)

Country Link
US (1) US4102996A (https=)
JP (4) JPS53133628A (https=)
BE (1) BE866096A (https=)
CA (1) CA1106279A (https=)
DE (1) DE2816864C2 (https=)
DK (1) DK158678C (https=)
FR (1) FR2387656A1 (https=)
GB (3) GB1596592A (https=)
HK (3) HK67684A (https=)
IE (1) IE46793B1 (https=)
IT (1) IT1102573B (https=)
LU (1) LU79477A1 (https=)
NL (1) NL7803625A (https=)
SG (1) SG41884G (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US4241175A (en) * 1978-12-18 1980-12-23 Merck & Co., Inc. Assay for hepatitis B core antibody
IL59007A (en) * 1978-12-22 1983-11-30 Biogen Nv Recombinant dna molecules coding for polypeptides displaying hepatitis b virus antigenicity,method of their production and compositions containing the same
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
CA1148859A (en) * 1979-06-14 1983-06-28 Lacy R. Overby Simultaneous assay of two hepatitis viruses using a solid phase
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
DE3479158D1 (en) * 1983-03-04 1989-08-31 Noctech Ltd Diagnostic agent, a process for its preparation and its use in diagnostic methods
US4547367A (en) * 1983-12-20 1985-10-15 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B core antigen vaccine
US4547368A (en) * 1983-12-20 1985-10-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitis B core antigen vaccine made by recombinant DNA
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
DE3604947A1 (de) * 1986-02-17 1987-08-20 Biotest Pharma Gmbh Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids
EP0341439B1 (en) * 1988-05-11 1993-08-04 Abbott Laboratories Method for increasing specificity in competitive immunoassays
BR0205774A (pt) * 2002-02-27 2004-04-20 Fundacao De Amparo A Pesquisa Sistema adjuvante para produção de anticorpos, vacina e uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
GB1518582A (en) * 1975-11-17 1978-07-19 Community Blood Council Viral hepatitis vaccine
DE2611723C3 (de) * 1976-03-19 1978-09-21 The Green Cross Corp., Osaka (Japan) Verfahren zur Herstellung von einheitlichen kugelförmigen HBsAg-Teilchen
NL7711378A (nl) * 1976-11-02 1978-05-05 Merck & Co Inc Werkwijze voor het bereiden van preparaten die dane-deeltjes bevatten.

Also Published As

Publication number Publication date
HK67784A (en) 1984-09-07
FR2387656A1 (fr) 1978-11-17
IE46793B1 (en) 1983-09-21
JPS58180430A (ja) 1983-10-21
DK158678C (da) 1990-12-31
GB1596593A (en) 1981-08-26
JPS57201854A (en) 1982-12-10
US4102996A (en) 1978-07-25
BE866096A (fr) 1978-10-18
DK158678B (da) 1990-07-02
DE2816864C2 (de) 1985-08-14
IT1102573B (it) 1985-10-07
JPS57203016A (en) 1982-12-13
GB1596591A (en) 1981-08-26
IE780716L (en) 1978-10-20
JPS53133628A (en) 1978-11-21
JPS6141897B2 (https=) 1986-09-18
CA1106279A (en) 1981-08-04
NL7803625A (nl) 1978-10-24
FR2387656B1 (https=) 1982-02-19
LU79477A1 (fr) 1978-11-28
DK171178A (da) 1978-10-21
DE2816864A1 (de) 1978-10-26
HK67684A (en) 1984-09-07
IT7848873A0 (it) 1978-04-12
SG41884G (en) 1985-03-08
HK67584A (en) 1984-09-07

Similar Documents

Publication Publication Date Title
GB1596592A (en) Hb ab human plasma
Dienstag et al. Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen
Barin et al. Immune response in neonates to hepatitis B vaccine
Stevens et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization
Stevens et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
Szmuness et al. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report
Cossart et al. Parvovirus-like particles in human sera
Soulier et al. Prevention of virus B hepatitis (SH hepatitis)
HOOFNAGLE et al. Passive-active immunity from hepatitis B immune globulin: reanalysis of a Veterans Administration Cooperative Study of needle-stick hepatitis
CA1066191A (en) Hepatitis b vaccine
Zanetti et al. Hepatitis B vaccination of 113 hemophiliacs: Lower antibody response in anti‐LAV/HTLV‐III‐positive patients
Chang et al. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus
US4164565A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
Lee et al. Chronic hepatitis B virus infection in an anti‐HBC–nonreactive blood donor: Variant virus or defective immune response?
Seidl et al. Transmission of diseases by blood transfusion
US4118478A (en) Vaccine manufacture for active immunization containing hepatitis B surface antigen and associated antigen
US4118479A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
Esteban et al. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: Efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low‐prevalence area
Al-Fawaz et al. Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major.
US4234564A (en) Hepatitis B core antigen composition
Ponzetto et al. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins
Francis Selective primary health care: strategies for control of disease in the developing world. III. Hepatitis B virus and its related diseases
Lindenmann [25] Induction of chick interferon: Procedures of the original experiments
Hilgartner AIDS in the transfused patient
IE46794B1 (en) Hb c ab human plasma

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930418